EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CT Radiomics Models Did Not Outperform Experts in Predicting [68Ga]Ga-PSMA-PET Positivity in Prostate Cancer Lymph Node Staging

Thula Cannon Walter-Rittel iD, Boris Gorodetski, Alexander Hartenstein, Julian Rogasch iD, Imke Schatka, Holger Amthauer iD, Marcus Makowski, Charlie Alexander Hamm iD, Tobias Penzkofer iD

Current Oncology · 02.03.2026 · 33 (3) · 146

DOI: 10.3390/curroncol33030146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 02.03.2026. Verfasst von Thula Cannon Walter-Rittel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Auguste…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Gallium Radioisotopes, Lymph Nodes. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Ministry of Education and Research Germany, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of [68Ga]Ga-PSMA-PET/CT for prostate cancer (PCa) staging is limited by cost and availability. This study evaluates whether radiomic features from contrast-enhanced (CE) CT can predict PSMA-positive lymph nodes (LNs) as a surrogate for metastasis.

Methods

A retrospective study of 447 patients included 2537 segmented LNs (425 PET-positive, 2112 PET-negative). Two uroradiologists assessed 417 LNs on CE-CT using a four-point Likert scale. Radiomic features were extracted, selected using four algorithms, and analyzed with six model-building methods. Model performance was compared to radiologist ratings.

Results

Radiomic models achieved an accuracy of 0.77–0.85, sensitivity of 0.85–0.91, and specificity of 0.74–0.85. Compared to radiologists, models had higher NPV (0.97–0.98 vs. 0.96) and sensitivity (0.85–0.91 vs. 0.76), but radiologists had superior accuracy (0.95 vs. 0.77–0.85) and specificity (0.97–0.98 vs. 0.74–0.85). In a subanalysis of LNs rated as probably benign or malignant, expert radiologists outperformed the algorithm with greater specificity and PPV (p < 0.005). A density threshold of >27 HU predicted PSMA-positive LNs with 0.79 accuracy, 0.87 sensitivity, and 0.78 specificity.

Conclusions

While radiomics did not outperform expert radiologists, the single first-order parameter CT density >27 HU was predictive of PSMA-positive LNs. Clinical Relevance Statement: Radiomic models did not outperform expert uroradiologists. However, in high-volume or resource-limited settings lacking access to [68Ga]Ga-PSMA-PET/CT, they may help improve LN assessment in PCa patients with CT alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyGallium RadioisotopesLymph NodesRadiomicsMaleHumansRetrospective StudiesNeoplasm StagingLymphatic MetastasisGallium IsotopesAgedEdetic AcidOligopeptidesTomography, X-Ray ComputedMiddle Aged

Stichwörter der Autor:innen

computed tomography (CT)diagnostic imaginglymph node metastasisprostate cancerradiomics

Substanzen

Gallium Radioisotopesgallium 68 PSMA-11Gallium IsotopesEdetic AcidOligopeptides

Autor:innen und Institutionen

  • Department of Radiology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Bayer AG, Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, Germany.
  • Department of Nuclear Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Berlin Institute of Health, Charité Platz 1, 10117 Berlin, Germany.
  • Department of Radiology, Klinikum Rechts Der Isar, Technical University Munich, Ismaninger Str. 22, 81675 Munich, Germany.

ORCID-Profile: Thula Cannon Walter-Rittel, Julian Rogasch, Holger Amthauer, Charlie Alexander Hamm, Tobias Penzkofer

Förderung

  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin
  • Ministry of Education and Research Germany
  • German Research Foundation
  • European Union
  • Berlin Institute of Health
  • Ministry of Education and Research
  • Siemens Healthineers
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Walter-Rittel, T. C., Gorodetski, B., Hartenstein, A., Rogasch, J., Schatka, I., Amthauer, H., Makowski, M., Hamm, C. A., & Penzkofer, T. (2026). CT Radiomics Models Did Not Outperform Experts in Predicting [68Ga]Ga-PSMA-PET Positivity in Prostate Cancer Lymph Node Staging. Current Oncology, 33(3), 146. https://doi.org/10.3390/curroncol33030146

Vancouver

Walter-Rittel TC, Gorodetski B, Hartenstein A, Rogasch J, Schatka I, Amthauer H, et al. CT Radiomics Models Did Not Outperform Experts in Predicting [68Ga]Ga-PSMA-PET Positivity in Prostate Cancer Lymph Node Staging. Current Oncology. 2026;33(3):146. doi:10.3390/curroncol33030146

BibTeX
@article{WalterRittel2026,
  author = {Walter-Rittel, Thula Cannon and Gorodetski, Boris and Hartenstein, Alexander and Rogasch, Julian and Schatka, Imke and Amthauer, Holger and Makowski, Marcus and Hamm, Charlie Alexander and Penzkofer, Tobias},
  title = {CT Radiomics Models Did Not Outperform Experts in Predicting [68Ga]Ga-PSMA-PET Positivity in Prostate Cancer Lymph Node Staging},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {146},
  doi = {10.3390/curroncol33030146}
}
Kostenlos starten →